BEST UNLIMITED TURBO LONG CERTIFICATE - ELI LILLY & CO | Market Closed - Euronext Paris 12:30:00 2024-06-26 pm EDT | ||
| 22.39 EUR | +0.91% |
|
| Current month | +23.51% | ||
| 1 month | +25.28% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 22.39 | +0.91% |
| 24-06-25 | 22.19 | +0.49% |
| 24-06-24 | 22.08 | +2.56% |
| 24-06-21 | 21.53 | -1.42% |
| 24-06-20 | 21.84 | +0.70% |
Real-time Euronext Paris
Last update June 26, 2024 at 12:30 pm EDT
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | 
Société Générale
|
| IZ53S | |
| ISIN | DE000SW13W92 |
| Date issued | 2023-08-10 |
| Strike | 429.9 $ |
| Maturity | Unlimited |
| Parity | 20 : 1 |
| Emission price | 5.98 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 22.64 € |
|---|---|
| Lowest since issue | 5.71 € |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- IZ53S Certificat
